MetaSight Diagnostics: Funding, Investors & Team (Sep 2026)
MetaSight Diagnostics, a health technology company, is on a mission to create affordable and precise liquid biopsy diagnostics for early detection of a variety of chronic and acute diseases, utilizing proprietary, cost-effective mass spectrometry technologies (metabolomics, lipidomics and proteomics). The company has created the world’s largest and most comprehensive serum metabolomics dataset linked with Electronic Health Records and is pursuing additional omics. This unprecedented platform is used by MetaSight’s team of experts in analytical chemistry, AI, and medicine to develop and commercialize diagnostic products to improve human health.
MetaSight Diagnostics has raised $8.0M across 1 funding round on record, the most recent a Series A of $8.0M announced in Nov 2024.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
MetaSight Diagnostics Company Profile and Key Stats
Latest funding round on record: Nov 2024.
MetaSight Diagnostics Funding Rounds
MetaSight Diagnostics Founders and Leadership Team
Contact details for the MetaSight Diagnostics team: 1 of 1 has an email address on file.
Start 14-day free trial →MetaSight Diagnostics Funding Compared to Other Health Care Startups
MetaSight Diagnostics' latest round of $8.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MetaSight Diagnostics in Health Care and Rehovot
Companies Similar to MetaSight Diagnostics
QuantHealth is an organization that produces software using artificial intelligence technology for drug…
Inspira Technologies is a cutting-edge medical technology company that specializes in the acute respiratory…
Alpha Tau Medical is an Israeli medical device company that focuses on research, development and…
Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma…
Vortex Imaging develops medical imaging devices.
Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and…
VISIONIX develops, manufactures and distributes innovative equipment and provides a complete solution for…
Fize Medical is a health care company based in Israel.
Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation,…
TopGum has developed a highly scalable patent-pending delivery system with the capacity to deliver a wide…
Nanox offers the Nanox System as a preventative healthcare Medical Screening As A Service (MSaaS). Nanox…
Microbot Medical is a company that creates innovative medical devices using micro-robotic technology. They…
MetaSight Diagnostics Funding FAQs
What does MetaSight Diagnostics do?
MetaSight Diagnostics, a health technology company, is on a mission to create affordable and precise liquid biopsy diagnostics for early detection of a variety of chronic and acute diseases, utilizing proprietary, cost-effective mass spectrometry technologies (metabolomics, lipidomics and proteomics). The company has created the world’s largest and most comprehensive serum metabolomics dataset linked with Electronic Health Records and is pursuing additional omics. This unprecedented platform is used by MetaSight’s team of experts in analytical chemistry, AI, and medicine to develop and commercialize diagnostic products to improve human health.
How much funding has MetaSight Diagnostics raised?
MetaSight Diagnostics has raised $8.0M across 1 round on record. The most recent is a Series A of $8.0M announced in Nov 2024.
When did MetaSight Diagnostics last raise funding?
MetaSight Diagnostics' most recent funding round on record is a Series A of $8.0M, announced in Nov 2024.
Who founded MetaSight Diagnostics?
FundedIQ lists Tomer Shlomi (Founder) at MetaSight Diagnostics.
Where is MetaSight Diagnostics headquartered?
MetaSight Diagnostics is based in Rehovot, Hamerkaz, Israel.
How many employees does MetaSight Diagnostics have?
MetaSight Diagnostics is in the 11-50 employee band.
How does MetaSight Diagnostics' funding compare to other Health Care startups?
MetaSight Diagnostics' latest round of $8.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's MetaSight Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MetaSight Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.